Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TBPH Theravance Biopharma Inc.

交易中 09-18 11:51:39 EDT

8.24

+0.00

0.00%

最高8.32	最低8.21	成交量3.06万
今开8.29	昨收8.24	日振幅1.34%
总市值4.03亿	流通市值1.50亿	总股本4,892万
成交额25.31万	换手率0.17%	流通股本1,819万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TBPH","market":"US","secType":"STK","nameCN":"Theravance Biopharma Inc.","latestPrice":8.24,"timestamp":1726674644596,"preClose":8.24,"halted":0,"volume":30626,"delay":0,"floatShares":18192209,"shares":48922083,"eps":-0.919218,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"09-18 11:51:39 EDT","open":8.29,"high":8.32,"low":8.21,"amount":253098.56229799998,"amplitude":0.01335,"askPrice":8.25,"askSize":211,"bidPrice":8.24,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.919218,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1726689600000},"adr":0,"listingDate":1400212800000,"adjPreClose":8.24,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":8.24,"preClose":8.24,"latestTime":"18:26 EDT","volume":10346,"amount":85250.09,"timestamp":1726612011809},"volumeRatio":0.546228,"impliedVol":0.0238,"impliedVolPercentile":0.0079},"requestUrl":"/m/hq/s/TBPH/wiki","defaultTab":"wiki","newsList":[{"id":"2458698940","title":"Theravance Biopharma, Inc.盘中异动 快速上涨5.22%报8.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458698940","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458698940?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:06","pubTimestamp":1723471608,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时06分，Theravance Biopharma, Inc.股票出现异动，股价急速拉升5.22%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Revance Therapeutics, Inc.、60 Degrees Pharmaceuticals, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、Revance Therapeutics, Inc.较为活跃，换手率分别为260.18%、58.62%、34.26%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为91.10%、40.71%、39.67%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220648af9716dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220648af9716dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2458692733","title":"Theravance Biopharma, Inc.2024财年第二财季实现净利润-16.53百万美元，同比减少5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458692733","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458692733?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:08","pubTimestamp":1723392524,"startTime":"0","endTime":"0","summary":"8月12日，Theravance Biopharma, Inc.公布财报，公告显示公司2024财年第二财季净利润为-16.53百万美元，同比减少5.62%；其中营业收入为14.26百万美元，同比增加3.71%，每股基本收益为-0.34美元。机构评级：截至2024年8月12日，当前有5家机构对Theravance Biopharma, Inc.目标价做出预测，其中目标均价为13.20美元，其中最低目标价为9.00美元，最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200090195904148&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200090195904148&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH"],"gpt_icon":0},{"id":"2457287788","title":"Theravance Biopharma, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457287788","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457287788?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:47","pubTimestamp":1723042035,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日22时47分，Theravance Biopharma, Inc.股票出现波动，股价急速拉升5.11%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.23%。其相关个股中，Aditxt, Inc.、G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为2743.70%、833.35%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为76.23%、69.66%、47.31%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080722471596824d01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080722471596824d01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2457007970","title":"成分股Castle Biosciences收涨13.96%，Exscientia ADR涨13.38%，和黄医药（HCM）涨10.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457007970","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457007970?lang=zh_cn&edition=full","pubTime":"2024-08-07 05:37","pubTimestamp":1722980247,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["LXRX","00013","BK1587","BK4531","BK4585","BK4588","BK4139","TBPH","EXAI","HCM","BK1588","BK4007","LENZ","BK1191"],"gpt_icon":0},{"id":"2457085400","title":"HC Wainwright &amp; Co.：维持Theravance Biopharma(TBPH.US)评级，由买入调整至买入评级, 目标价由20.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457085400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457085400?lang=zh_cn&edition=full","pubTime":"2024-08-07 03:01","pubTimestamp":1722970919,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2457075780","title":"TD Cowen：维持Theravance Biopharma(TBPH.US)评级，由持有调整至持有评级, 目标价由10.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457075780","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457075780?lang=zh_cn&edition=full","pubTime":"2024-08-07 00:46","pubTimestamp":1722962768,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4207","BK4566","TD","BK4007","TBPH","BK4585"],"gpt_icon":0},{"id":"2457028887","title":"Theravance Biopharma, Inc.盘中异动 股价大跌12.51%报8.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457028887","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457028887?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:33","pubTimestamp":1722951194,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时33分，Theravance Biopharma, Inc.股票出现异动，股价快速跳水12.51%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为782.17%、308.85%、205.07%，振幅较大的相关个股有Vbi Vaccines, Inc.、Actinium Pharmaceuticals, Inc. 、Tenax Therapeutics, Inc.，振幅分别为76.79%、22.98%、17.81%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062133149f1436a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408062133149f1436a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2453792769","title":"Theravance Biopharma, Inc.盘中异动 股价大涨5.02%报10.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453792769","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453792769?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:38","pubTimestamp":1721662718,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日23时38分，Theravance Biopharma, Inc.股票出现波动，股价快速拉升5.02%。截至发稿，该股报10.05美元/股，成交量7.3075万股，换手率0.15%，振幅4.49%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722233839aefacd16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722233839aefacd16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2451621438","title":"Theravance Biopharma, Inc.盘中异动 快速上涨5.34%报9.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451621438","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451621438?lang=zh_cn&edition=full","pubTime":"2024-07-15 23:07","pubTimestamp":1721056070,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日23时07分，Theravance Biopharma, Inc.股票出现波动，股价急速拉升5.34%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Scinai Immunotherapeutics Ltd、Artelo Biosciences, Inc.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为3122.58%、113.51%、107.12%，振幅较大的相关个股有Aeon Biopharma, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Scinai Immunotherapeutics Ltd，振幅分别为150.36%、74.53%、69.21%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715230750af926753&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715230750af926753&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2450439837","title":"Theravance Biopharma, Inc.盘中异动 急速上涨5.05%报9.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450439837","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450439837?lang=zh_cn&edition=full","pubTime":"2024-07-12 00:14","pubTimestamp":1720714448,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日00时14分，Theravance Biopharma, Inc.股票出现波动，股价快速拉升5.05%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Neximmune, Inc.、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc涨幅较大，Neximmune, Inc.、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited较为活跃，换手率分别为809.97%、642.37%、611.57%，振幅较大的相关个股有Neximmune, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为172.94%、149.14%、97.11%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712001408aef941f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712001408aef941f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2437766455","title":"Theravance Biopharma, Inc.盘中异动 早盘股价大跌5.01%报8.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437766455","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437766455?lang=zh_cn&edition=full","pubTime":"2024-05-23 22:35","pubTimestamp":1716474936,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日22时35分，Theravance Biopharma, Inc.股票出现波动，股价快速下跌5.01%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Geovax Labs Inc C/Wts 29/09/2025、Altamira Therapeutics Ltd.涨幅较大，Altamira Therapeutics Ltd.、Theriva Biologics, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为1936.10%、100.80%、47.65%，振幅较大的相关个股有Altamira Therapeutics Ltd.、180 Life Sciences Corp C/Wts 07/11/2025、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为51.74%、41.43%、39.13%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405232235369680f4e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405232235369680f4e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2436181195","title":"Theravance Biopharma, Inc.2024财年第一财季实现净利润-11.66百万美元，同比增加47.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436181195","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436181195?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:25","pubTimestamp":1716049519,"startTime":"0","endTime":"0","summary":"3月31日，Theravance Biopharma, Inc.公布财报，公告显示公司2024财年第一财季净利润为-11.66百万美元，同比增加47.22%；其中营业收入为14.50百万美元，同比增加39.16%，每股基本收益为-0.24美元。机构评级：截至2024年3月31日，当前有5家机构对Theravance Biopharma, Inc.目标价做出预测，其中目标均价为15.40美元，其中最低目标价为10.00美元，最高目标价为21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051900253187781104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051900253187781104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH"],"gpt_icon":0},{"id":"2433002479","title":"Theravance Biopharma, Inc.盘中异动 急速上涨6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433002479","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433002479?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:30","pubTimestamp":1715002257,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时30分，Theravance Biopharma, Inc.股票出现异动，股价大幅拉升6.24%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。消息层面，截至21时30分，《Theravance Biopharma股东增持149.91万股普通股股份，价值约1,311.73万美元》资讯为影响Theravance Biopharma, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621305787e85cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621305787e85cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2432932664","title":"Theravance Biopharma, Inc.盘中异动 下午盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432932664","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432932664?lang=zh_cn&edition=full","pubTime":"2024-05-03 02:54","pubTimestamp":1714676046,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日02时54分，Theravance Biopharma, Inc.股票出现波动，股价急速拉升5.09%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Jaguar Health, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为4591.54%、698.59%、156.59%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为164.96%、86.54%、49.56%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050302540787e8561d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050302540787e8561d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2432588024","title":"Theravance Biopharma, Inc.盘中异动 急速下跌5.01%报8.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432588024","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432588024?lang=zh_cn&edition=full","pubTime":"2024-05-01 02:51","pubTimestamp":1714503070,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日02时51分，Theravance Biopharma, Inc.股票出现异动，股价快速下挫5.01%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Eliem Therapeutics, Inc涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1522.35%、237.13%、30.27%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Eliem Therapeutics, Inc、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为60.76%、55.38%、48.00%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010251107a57ca44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010251107a57ca44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2427832641","title":"成分股Marinus Pharma收跌82.71%，创该公司2014年美国IPO以来最差单日表现，这家药品研发公司称，其癫痫药品Ganaxolone没能在后期临床试验中满足关于提前结束研究的标准；","url":"https://stock-news.laohu8.com/highlight/detail?id=2427832641","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2427832641?lang=zh_cn&edition=full","pubTime":"2024-04-16 05:57","pubTimestamp":1713218276,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4120","BK4121","BK4139","BK4007","BK4585","BK4588","BK1141","BV","BK4505","BK1583","LENZ","03347","BK1576","BK4539","LYEL","PACB","TBPH","ATAI"],"gpt_icon":0},{"id":"2427750975","title":"成分股NantKwest收跌15.68%，Arcutis跌14.14%，Enliven Therapeutics跌11.50%，Summit Therapeutics Plc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2427750975","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2427750975?lang=zh_cn&edition=full","pubTime":"2024-04-13 04:33","pubTimestamp":1712954032,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4139","TBPH","LYEL","LENZ","BK4505","BK4007","BK4539"],"gpt_icon":0},{"id":"2426780727","title":"Theravance Biopharma, Inc.盘中异动 早盘大幅上涨6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426780727","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426780727?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:31","pubTimestamp":1712928668,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时31分，Theravance Biopharma, Inc.股票出现异动，股价大幅上涨6.05%。Theravance Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Theravance Biopharma, Inc.公司简介：Theravance Biopharma Inc 是一家多元化的生物制药公司，专注于器官选择性药物的发现、开发和商业化。该信息摘要如下：Theravance Biopharma获BTIG首次覆盖，给予买入评级, 目标价21.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213109876f4540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412213109876f4540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TBPH"],"gpt_icon":0},{"id":"2426859407","title":"Theravance Biopharma(TBPH.US)获BTIG首次覆盖，给予买入评级, 目标价21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426859407","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426859407?lang=zh_cn&edition=full","pubTime":"2024-04-12 19:41","pubTimestamp":1712922075,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBPH","BK4007"],"gpt_icon":0},{"id":"2426218072","title":"成分股Alpine Immune Sciences收涨36.90%，Enliven Therapeutics涨20.18%，Vera Therapeutics、Savara、Janux Therapeutics、AnaptysBio、Alx Oncology Holdings涨17.","url":"https://stock-news.laohu8.com/highlight/detail?id=2426218072","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426218072?lang=zh_cn&edition=full","pubTime":"2024-04-12 05:02","pubTimestamp":1712869355,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4539","BK4588","BK4007","LENZ","BK4139","BK4585","TBPH","APGE","JANX","VERA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.theravance.com","stockEarnings":[{"period":"1week","weight":0.0135},{"period":"1month","weight":0.0123},{"period":"3month","weight":-0.0283},{"period":"6month","weight":-0.0804},{"period":"1year","weight":-0.07},{"period":"ytd","weight":-0.2669}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Theravance Biopharma, Inc.，于2013年7月注册为开曼群岛豁免股份有限公司。该公司是一家生物制药公司，主要专注于药物的发现、开发和商业化。该公司的核心宗旨是创造能够改变人们生活的药物。该公司利用数十年的专业知识，开发了FDA批准的YUPELRI（revefenacin）吸入溶液，用于慢性阻塞性肺病患者的维持治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.024681},{"month":2,"riseRate":0.3,"avgChangeRate":0.011183},{"month":3,"riseRate":0.4,"avgChangeRate":0.013288},{"month":4,"riseRate":0.5,"avgChangeRate":0.034332},{"month":5,"riseRate":0.4,"avgChangeRate":-0.07018},{"month":6,"riseRate":0.2,"avgChangeRate":-0.046131},{"month":7,"riseRate":0.363636,"avgChangeRate":0.003912},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.000873},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.035771},{"month":10,"riseRate":0.4,"avgChangeRate":-0.033295},{"month":11,"riseRate":0.7,"avgChangeRate":0.084893},{"month":12,"riseRate":0.6,"avgChangeRate":0.056025}],"exchange":"NASDAQ","name":"Theravance Biopharma Inc.","nameEN":"Theravance Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Theravance Biopharma Inc.(TBPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Theravance Biopharma Inc.,TBPH,Theravance Biopharma Inc.股票,Theravance Biopharma Inc.股票老虎,Theravance Biopharma Inc.股票老虎国际,Theravance Biopharma Inc.行情,Theravance Biopharma Inc.股票行情,Theravance Biopharma Inc.股价,Theravance Biopharma Inc.股市,Theravance Biopharma Inc.股票价格,Theravance Biopharma Inc.股票交易,Theravance Biopharma Inc.股票购买,Theravance Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Theravance Biopharma Inc.(TBPH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Theravance Biopharma Inc.(TBPH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况